Company intelligence / Profile preview

Cristália

Itapira, São Paulo, Brazil

Ownership: Private
Employees: ~2500
Development stage: Commercial

Overview

Cristália is the leading producer of anesthetics in Latin America with a strong portfolio in hospital medicines including injectables and narcotic analgesics. It supplies about 95% of Brazilian hospitals with anesthetics. Its biotech division produces APIs for oncology to reduce Brazil’s dependence on imports. The company holds over 130 patents globally and exports to more than 30 countries[1][2][3][6].

Therapeutic areas: DermatologyOtherOncologyNeurologyInfectious Diseases
Modalities: Small molecules (APIs, finished dosages)Biologics (biological APIs, biosimilars)Enzymes (e.g., collagenase)Antibodies (limited pipeline presence)
Industry: Biotech

Drug pipeline

5 assets

lodenafil carbonate

4 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Cristália.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cristália.

Explore the full profile